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 Abstract  
With age, the brain undergoes both structural and functional alterations, probably resulting in 
reported cognitive declines. Relatively few investigations have sought to identify those areas 
that remain intact with aging, or undergo the least deterioration, which might underlie 
cognitive preservations. Our aim here was to establish a comprehensive profile of both 
structural and functional changes in the aging brain, using up-to-date voxel-based 
methodology (i.e. optimized VBM procedure; resting-state 
18
FDG-PET with correction for 
partial volume effects) in 45 optimally healthy subjects aged 20-83 years. Negative and 
positive correlations between age and both gray matter volume and 
18
FDG uptake were 
assessed. The frontal cortex manifested the greatest deterioration, both structurally and 
functionally, whereas the anterior hippocampus, the thalamus and (functionally) the posterior 
cingulate cortex were the least affected. Our results support the developmental theory which 
postulates that the first regions to emerge phylogenetically and ontogenetically are the most 
resistant to age effects, and the last ones the most vulnerable. Furthermore, the lesser affected 
anterior hippocampal region, together with the lesser functional alteration of the posterior 
cingulate cortex, appear to mark the parting of the ways between normal aging and 
Alzheimer‟s disease, which is characterized by early and prominent deterioration of both 
structures. 
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1. Introduction  
 
With age, the brain undergoes structural and functional deterioration, which is thought 
to be responsible for the reported cognitive decline [3,62,47]. Identifying the best-preserved 
areas, or rather the least altered, would perhaps provide insight into cognitive preservation 
with age [30,56], including “cognitive reserve”, i.e. the maintenance of cognitive performance 
even when specific brain areas can no longer support the relevant processes [9]. 
Overall, the literature consistently reports global brain atrophy in normal adults, generally 
more pronounced in frontal areas (for a review, [63]), often followed by parietal, temporal and 
insular gray matter (GM) loss [1,2,29,31,70,81,87]. As a result of different methodologies and 
inclusion criteria, other brain areas have been the matter of conflicting findings, notably the 
hippocampus. The “region of interest” procedure (ROI), which consists in selecting specific 
brain regions to address specific hypotheses, sometimes showed the hippocampus to undergo 
structural deterioration [34,35,85], occasionally as strong as the prefrontal cortex [66,67], but 
sometimes revealed no significant correlation between hippocampal volume and age, 
suggesting that this structure may be relatively preserved in normal aging [8,17,40,80]. Since 
this structure and adjacent areas are deteriorated first and foremost in Alzheimer‟s disease 
[4,19,36], differentiating the mesial temporal GM evolution in normal and pathological aging 
constitutes a key issue. Recently, structural brain changes have been investigated using the 
„optimized Voxel-Based Morphometry procedure‟ (VBM), which makes it possible to assess 
the whole brain without postulating prior hypotheses about specific regions of the brain. 
Authors have systematically reported GM loss in the frontal lobe with aging 
[1,29,31,37,38,81,84,87], also affecting the insula, Heschl gyrus, anterior cingulate cortex, 
sensorimotor areas and cerebellum. In spite of the objectivity of this method, studies led to 
somewhat contradictory results regarding the hippocampus: some authors have found this 
structure to be preserved with aging [29,31], whereas others have reported structural 
deterioration [38,81,84,87]. This discrepancy may result from the samples selected in these 
studies. Thus, preservation of the hippocampus was found when the sample covered a large 
life span (17-79 years in Good et al. [29] and 8-79 in Grieve et al. [31]), whereas atrophy was 
observed when age effects were evaluated within older samples, i.e. 50 or 60 years and over 
([38,70,81, but see [84]). This suggests a non-linearity of hippocampal GM volume time 
course over time in normal aging, as recently supported by Allen et al. [2]. These authors, 
using ROI analyses (including frontal lobe, hippocampal and parahippocampal areas) by 
decades, found that the frontal cortex volume declined linearly and had the strongest age 
association, whereas the hippocampal volume remained steady until about 60 years of age, 
while thereafter its volume began to rapidly decline. Other methods have contributed to 
knowledge on age-related morphological changes, such as thickness of the cerebral cortex 
[75]. The authors showed prominent atrophy of the prefrontal cortex, and relative sparing of 
the temporal and parahippocampal cortices, corroborating several previous volumetric 
findings (see also [68]). 
A few longitudinal studies have also been performed to address the issue of age-related GM 
volume time course. Most have revealed prominent GM loss in prefrontal regions 
[40,59,65,71,76] with smaller but significant decline in other regions, notably in mesial 
temporal areas. Hippocampal GM losses have been found at a relatively advanced age 
[40,65,76] or in subjects who had received a diagnosis of arterial hypertention [65]. The only 
longitudinal voxel-based analysis has generated similar results, i.e. a mesial temporal tissue 
loss, at a lesser degree however than the prefrontal cortex [69]. Overall, a hippocampal 
atrophy has been often reported in the available longitudinal studies, but it appears to occur 
late in life, and even then to be relatively modest.  
 
Resting-state SPECT and PET studies have consistently highlighted a metabolic deterioration 
of the frontal and anterior cingulate cortices [12,28,32,42,44, 48,49,54,58,86,87,89]. Of them, 
however, few have addressed the issue of regional metabolic preservation with aging 
[32,49,58,86]. All these studies being considered together, the occipital and posterior 
cingulate cortices, cerebellum, thalamus, basal ganglia and limbic structures have been 
reported to be the least altered. However, many contradictory results preclude any firm 
conclusion, given that decreased metabolism has been found in the limbic areas [42], basal 
ganglia [32], or posterior cingulate cortex [89]. Some methodological limitations could 
explain these discrepancies. Regional cerebral blood flow (rCBF) has been used as a marker 
of synaptic activity [12,42,44,48], but this is suboptimal, as perfusion can be affected by many 
physiological variables. In addition, the partial volume effect (PVE), where the measured 
radiotracer concentration in small structures is influenced by surrounding structures [61], is 
particularly marked when cortical atrophy is present, as in normal aging. PVE correction 
(PVEc) was performed very recently in two PET studies, providing the most reliable results in 
this field so far [33,87]. Only the latter study [87] sought to highlight both deterioration and 
preservation. The authors report that only the right precentral gyrus remained relatively intact 
across age in men, as opposed to the left superior temporal and postcentral areas in women; 
they did not report data for the group as a whole. Finally, to our knowledge, a single recent 
study has longitudinally assessed functional age-related changes in the resting-state: Beason-
Held et al. [5] observed decreasing rCBF over 9 years mainly affecting the frontal areas, 
superior and middle temporal gyri, inferior occipital regions, mid-cingulate gyrus and mid-
level thalami. Increased relative rCBF was observed mainly in frontal white matter, middle 
temporal gyrus, left hippocampus, inferior parietal, middle occipital and cerebellum, inferior 
part of the right thalamus, and putamen.  
 
To our knowledge, no study has assessed both structural and functional deterioration 
and relative preservation in normal aging in the same sample and using up-to-date 
methodology, i.e. voxel-based analyses, the optimized-VBM procedure and PVEc.   
2. Methods  
 2.1. Study population  
Forty-five healthy subjects aged between 20 and 83 years (mean: 49.4 ± 18 years, 24 females 
and 21 males) were selected according to stringent prospective inclusion/exclusion criteria. 
All were right-handed, had a minimum educational background of 9 years of schooling 
(mean: 13.1 + 2.5 years) and were living at home. A semi-structured questionnaire was used 
by senior clinical neurologists (FV, JCB) to screen subjects‟ health. They were enrolled in 
these studies based on lack of abnormality of clinical, MRI, and neuropsychological 
examinations, as follows: 1) normal somatic examination, 2) body weight in the normal range, 
3) no known vascular risk factor and smoking <10 cigarettes per day, 4) no alcohol or coffee 
abuse, according to DSM4 criteria, 5) blood pressure within normal limits or corrected to, 6) 
no history or clinical evidence of sensorineural loss, dementia, or psychiatric disorder (a 
formal psychiatric interview was not performed), 7) no current use of medication (except birth 
control pills, oestrogen replacement therapy, anti-hypertensive drugs), and especially no use 
of centrally acting drugs (sleeping pills, antidepressant drugs) for at least 6 weeks, 8) normal 
standard T1-, T2- and/or FLAIR- weighted MRI, and notably no significant white matter T2- 
FLAIR-weighted hyperintensities (less than 5 pinpoint hyperintensities, size < 4 mm [46]). 
The Mattis dementia rating scale [45] was used for subjects over 50 years to exclude those 
suspected of neurodegenerative pathology (mean: 141.25 + 2.8). They also underwent 
cognitive tasks assessing episodic memory (using the ESR task [15,25]), semantic memory 
(categorical fluency, [13]) and working memory (verbal span). In no subject there was any 
evidence of significant cognitive decline beyond that expected for normal aging, and no 
subject complained about their memory. All subjects underwent the entire protocol within a 
maximum period of two months. 
This protocol was approved by the regional ethics committee. Subjects gave written consent 
to the procedure prior to the investigation.  
 
2.2. MRI data acquisition and processing  
The T1-weighted volume MRI scan consisted of a set of 128 adjacent axial slices parallel to 
the antero-posterior commissure (AC-PC) line, with a slice thickness of 1.5 mm and a voxel 
size of 0.94 x 0.94 mm, using the spoiled gradient echo sequence (SPGR) (repetition time 
(TR) = 10.3 ms; echo time (TE) = 2.1 ms; field of view (FOV) = 24 x 18 cm; matrix = 256 x 
192). All the MRI data sets were acquired from the same scanner (1.5 T Signa Advantage 
echospeed; General Electric) and with the same parameters. Standard correction for field 
inhomogeneities was applied. 
 
The MRI data were analyzed using the optimized automated VBM procedure fully described 
elsewhere [29]. Briefly, this procedure consisted in generating a customized template (based 
on the 45 subjects‟ scans), and the segmentation and normalization of the MRI images using 
the customized priors. The resulting optimized parameters were then applied to the original 
scans, which were segmented, modulated and smoothed with a 12-mm isotropic Gaussian 
kernel. The modulation step was used to incorporate volume changes during normalization 
into the analysis.  
 
2.3. PET data acquisition and processing 
Data were collected using the high-resolution ECAT Exact HR+ PET scanner with an 
isotropic resolution of 4.6 x 4.2 x 4.2 mm (axial FOV = 158 mm). The subjects fasted for at 
least 4 hours prior to scanning. The head was positioned on a headrest according to the 
cantho-meatal line and gently restrained with straps. 
18
FDG uptake was measured in the 
resting condition, with eyes closed, in a quiet and dark environment. A catheter was inserted 
into a vein in the arm to inject the radiotracer. Following 
68
Ga transmission scans, 3-5 mCi of 
18
FDG were injected as a bolus at time 0, and a 10-min PET data acquisition began 50 min 
post-injection. 63 planes were acquired with septa out (volume acquisition), using a voxel size 
of 2.2 x 2.2 x 2.43 mm (x, y, z). During the PET data acquisition, laser beams were projected 
onto ink marks drawn on the forehead in order to carry out continuous monitoring of head 
motion and correct it, if necessary.  
PET data were first corrected for PVE. We used an optimized voxel-based technique, 
originally devised by Müller-Gärtner et al. [52], and modified slightly by Rousset et al. [72]. 
This so-called „modified Müller-Gärtner‟ method is described in detail by Quarantelli et al. 
[61] and is fully implemented in “PVE-lab” software. It makes it possible to correct for both 
the loss of GM activity due to spill-out onto non-GM tissues, and increases in GM activity, 
due to the spill-in from adjacent white matter (WM). Unlike the classic Müller-Gärtner 
method, which extracts the WM tracer uptake value from a large WM region, the modified 
method performs a more accurate estimation of this WM value, based on the ROI method 
proposed by Rousset et al. [73]. The latter takes into account both the spill-in and spill-out 
effects on any possible pair of ROIs. 
In order to obtain accurate PET data, the images were subjected to coregistration onto their 
corresponding MR images and to spatial normalization on the same customized template as 
that used for the MR images. We used the mutual information coregistration approach of 
SPM2 (“between modality coregistration using information theory”; see [18]). PET data sets 
were resliced (2 x 2 x 2 mm) and smoothed with a 14-mm isotropic Gaussian filter to blur 
individual variations in gyral anatomy and to increase the signal-to-noise ratio.  
 
2.4. MRI and PET data analyses  
MRI and PET data were masked so that only GM voxels of interest were considered in further 
analyses. This mask was obtained by thresholding the customized GM template to an absolute 
value > 0.5, corresponding to more than 50% chance to belong to GM. The same mask was 
then applied to both MRI and PET datasets. Using the “single-subject: covariates only” 
routine of SPM2, with age as a covariate, correlations were computed across the 45 subjects. 
First, using the classic “no global normalization” routine of SPM, we assessed negative 
correlations between age and absolute GM volume to obtain absolute age-related GM volume 
loss (results are presented in the section 3.1). Second, the MRI data were re-analyzed 
separately using the “proportional scaling” routine of SPM. Dividing the intensity value of 
each voxel by the mean intensity value of all the voxels allowed us to assess positive 
correlations between age and relative GM voxel by voxel and then to highlight the regions 
that underwent less GM loss than the global age-related GM loss (results are presented in the 
section 3.2). Third, the classic and necessary “proportional scaling” routine was also applied 
to PVEc PET data to control for individual variations in total 
18
FDG uptake. To assess 
regional changes, both negative and positive voxel by voxel correlations were performed 
between neuroimaging data and age. All these analyses were performed using a statistical 
threshold of p<.01 FDR, corrected for multiple comparisons, with a minimum cluster size 
k=20.  
It must be noted that the results stemming from positive correlations between neuroimaging 
data and age would not be interpreted as “preserved regions”, which would be a misuse of 
language: these analyses do not indicate if the GM volume or the metabolism remains stable, 
they only mean that these areas undergo the least impairment in comparison with the mean of 
GM/FDG uptake age-related decrease. Thus, the terms “less/least impairment/deterioration/ 
decrease” will be preferred to that of “preservation‟. 
 
3. Results  
Tables 1 and 2 show the regions of significant links between GM volume (highest and lowest 
loss) and age. Results are illustrated in Figure 1A. Tables 3 and 4 show the regions of 
significant links between 
18
FDG uptake (highest and lowest decrease) and age. Results are 
illustrated in Figure 1B. 
 
3.1. Absolute GM volume loss (Table 1, Figure 1A) 
Absolute age-related GM volume loss was mainly located bilaterally in the frontal lobes 
(dorsolateral prefrontal cortex, sensorimotor areas and orbitofrontal regions). Atrophy was 
also found in the bilateral superior occipital and superior parietal cortices, the insular region 
surrounding the superior temporal areas, the posterior part of the hippocampus, the 
cerebellum and the periventricular areas spanning the caudate nuclei and anterior thalamic 
nucleus.  
3.2. Least GM volume decreases (Table 2, Figure 1A) 
The positive correlation between age and GM volume showed that the least GM decline was 
mainly located in the anterior right mesial temporal lobe structures (and the left counterpart at 
p<0.05 FDR corrected), including the anterior part of the hippocampus, entorhinal cortex and 




FDG uptake decreases (Table 3, Figure 1B)  
A relative age-related decrease in 
18
FDG uptake was found bilaterally in the superior medial 
frontal, motor, anterior and middle cingulate cortices, as well as in the bilateral parietal 
regions (with left-sided predominance), including the supramarginal, superior and inferior 
parietal cortices. The metabolic rate of the superior temporal pole encroaching on the insular 




FDG uptake decreases (Table 4, Figure 1B) 
The least 
18
FDG uptake decreases with aging was found in the bilateral mesial temporal lobes 
(hippocampus, amygdala and parahippocampal gyrus). The putamen, pallidum and lateral 
thalamic nuclei were metabolically less impaired, as well as the right posterior cingulate 
cortex and precuneus, both sides of the occipito-temporal cortex (calcarine, fusiform, lingual 




Our findings regarding absolute GM loss showed that aging mostly affects the 
neocortical areas, notably the prefrontal cortex, in accordance with the literature (see 
Introduction), and also the parietal cortex. Corroborating previous studies which had used the 
same optimized VBM methodology [29,31], we found that the thalamus (lateral nuclei) and 
the anterior hippocampal region showed the least impairment in older subjects, contrasting 
with GM loss in the anterior thalamic nuclei and a more caudal portion of the hippocampal 
formation. This finding may explain some of the discrepancies found in previous studies 
using the ROI method, as the ROI is potentially located in different places, while with voxel-
based analysis the exact location of significant results is not pre-specified. Also, using the 
former method, the hippocampal head was found to be more resilient to the normal aging 
process than the hippocampal tail [24,64], whereas in contrast a substantial decrease in 
anterior hippocampal volume has been observed in Alzheimer‟s disease [4,43,64]. Thus, this 
result signals a major difference between healthy aging and Alzheimer‟s disease.  
Overall, the data from many recent studies, including ours, can be combined now to 
provide quite a clear picture of the relationship of hippocampal volume to age in normal 
individuals. The hippocampal volume increases in children [82], until in the young adult, then 
remains relatively stable until the late 60's when it begins to decline (see introduction), giving 
rise to a curvilinear function. As we have studied very young adults in their 20's and only few 
individuals past age 70, a "linear" regression revealed no effect. Moreover, our findings 
highlighted different age effects in anterior and caudal hippocampal areas and it would be 
interesting to further study the hippocampal volume in all the lifespan, considering separately 
its different parts rather than the whole structure. Finally, it is worth noting that the gray 
matter losses in the frontal cortex and those in the hippocampus are very different, the decline 
in frontal cortex proceeding monotonically downward from an early age. 
Regarding the metabolic data, we found that the anterior brain areas, notably a large 
part of the superior medial prefrontal cortex and the anterior and middle parts of the cingulate 
cortex, were the most metabolically affected in normal aging. Most previous studies have 
reported decreased activity in frontal areas and the anterior cingulate gyrus with age, using 
SPECT [44], [
15
O]H2O-PET [5,12,42,48,54] or 
18
FDG-PET [28,32,49,58,86,87,89]. We also 
found that the decrease in 
18
FDG uptake affected other neocortical regions, including the 
parietal and temporal poles, thereby corroborating a number of previous studies. Ibanez et al. 
[33] failed to find any remaining hypometabolic areas after PVEc. However, differences in 
the population and statistics they selected may have induced a loss of statistical power in their 
study, as they have compared two small groups (young vs. older groups), rather than 
correlating PET data and age across the whole sample.   
 
Consistent with the literature, less metabolic decrease was found within the inferior temporal 
(fusiform cortex) and occipital areas (calcarine area and lingual gyrus) [32,49,58,86]. These 
cortical areas either form an extension, or are located very close to, the limbic and paralimbic 
areas, which were also less impaired. One of the limbic structures - the hippocampus - showed 
a lesser degree of metabolic impairment, thus confirming the findings of Willis et al. [86], 
who found „preserved‟ hippocampal relative CMRglc (cerebral metabolic rate of glucose), 
and those of a very recent longitudinal study [5] over 9 years in older healthy subjects which 
highlighted an increased relative rCBF in the left hippocampus. In the past, suboptimal 
methodology may have obscured structures of small size located close to the ventricles, such 
as the hippocampal structures, basal ganglia and thalamus, as PVE reduces the spatial 
resolution of the data and causes the metabolic rate to be underestimated. For instance, the 
failure to find a positive correlation between age and hippocampal metabolism in most of the 
studies that failed to correct for PVE, except those cited above, may reflect the contamination 
of hippocampal voxel values by the CSF values of the surrounding ventricles, which enlarge 
with age.  
It is worth noting that the posterior cingulate cortex is one of the least metabolically 
impaired areas with healthy aging. An increasing number of studies have consistently showed 
that this structure is the most metabolically impaired region in prodromal Alzheimer‟s disease 
[15,53], once again revealing a major difference between this neurodegenerative disease and 
normal aging [58,86]. By controlling for errors liable to generate inaccurate findings, our data 
provide further evidence that the subcortical nuclei (putamen, pallidum) and thalamus are 
quite spared by increasing age. Previous studies have yielded discrepant results regarding 
these structures, reporting either „preservation‟ [49,58,86], or alteration (before PVEc [33], 
see also [32]).  
 
From an evolutionary perspective, our structural findings support the “developmental 
hypothesis” postulated by Grieve et al. [31] to account for structural changes in normal aging. 
This hypothesis stipulates that the first structures to neurally develop are the most resistant to 
aging effects, whereas those that emerge during the latter stages of development are the first 
to deteriorate. Phylogenetically, the neocortex and, more specifically, the prefrontal cortex, 
belong to the neencephalon, corresponding to the third and last level of development of the 
central nervous system, while the hippocampus belongs to the archeocortex, which 
corresponds to the first level of development. The thalamus belongs to the paleocortex, 
second level of development. Ontogenesis follows the phylogenetic axis: histological and 
MRI analyses [60,62] of normal foetal brain development have highlighted the early 
maturation of the hippocampus and thalamus (see also [82]).  
 





FDG-PET studies of the postnatal maturation of the brain [16], the newborn 
period is characterized by a high metabolic rate in the mesial temporal region, cerebellar 
vermis, thalamus, basal ganglia, cingulate cortex and sensorimotor cortex. At three months, 
glucose metabolism increases in the parietal, occipital and temporal cortices. Frontal glucose 
consumption begins to increase later, between six and eight months. Thus, our results are 
broadly congruent with metabolic ontogenetic development. 
 
Our findings reveal a clear opposition between the decline in frontal structures and the 
clearly lesser alteration of GM volume and FDG uptake of the hippocampal region. They 
make an interesting contribution to our understanding not only of age-related memory 
impairment but also of spared processes in older subjects. Thus, these areas are known to 
subtend episodic memory, although their roles can be dissociated [9]. Although both the 
encoding and retrieval processes of episodic memory depend on frontal cortex integrity, some 
authors have suggested that the frontal cortex may be involved more in effortful strategic 
processes associated with memory retrieval, while the hippocampus is mainly engaged in the 
encoding and ecphoric processes [11,20,22,50,78]. Thus, our findings support the idea that 
episodic memory deficits associated with normal aging reflect above all a failure to 
implement an efficient strategy in the retrieval of episodic information, with encoding and 
ecphoric processes being relatively unaffected. Several lines of evidence from PET and fMRI 
activation studies [7,11,77,78,79] support this interpretation, demonstrating that frontal 
dysfunction during episodic memory tasks in older subjects reflects age-related changes in 
their retrieval strategies [77]. Activation studies have shown that, unlike young subjects where 
the frontal cortex is more heavily activated on the right than the left during retrieval (the 
HERA model, Hemispheric Encoding/Retrieval Asymmetry [83]), older adults show over-
activation (a bilateral pattern of frontal activity) (see the HAROLD model, Hemispheric 
Asymmetry Reduction in OLDer adults, [10]) or under-activation. Structural and functional 
bilateral frontal shrinkage would induce compensatory mechanisms, explaining why older 
adults display more frontal activity during retrieval tasks [57]. The contrast here with 
Alzheimer‟s disease is worth noting, where episodic memory impairment is associated with 
hippocampal dysfunction shown by correlative [15,20,21,26] and activation [23,55,79] 
studies.  
Our interpretation regarding the origin of memory decline in normal aging, especially 
concerning the medial temporal lobe, is in line with a recent longitudinal study [6] reporting 
functional age-related changes: the authors assessed memory over 9 years using PET in 25 
healthy and cognitively stable older adults. While subjects‟ performance did not decrease over 
time, widespread changes in relative rCBF were observed during memory tasks over time, 
particularly increasing activity in the medial temporal structures. The authors suggested that 
these changes might sustain memory performance in older subjects. The patterns they 
observed fit with the notion of preserved hippocampal function with advancing age in healthy 
individuals. Furthermore, the dissociation between the preservation of the anterior part of the 
hippocampal region and the deterioration of its caudal portion fits well with the idea of the 
preferential age-related maintenance of encoding processes, as suggested in the HIPER 
(hippocampal encoding/retrieval) model [39]. According to this model, the rostral portion of 
the hippocampus is particularly heavily involved in encoding processes, whereas its caudal 
portion is mainly involved in retrieval processes.  
 
Methodological considerations  
PET  
All PET data were expressed as relative values, since we used raw FDG uptake data, 
which have to be divided by the global mean because they have no physiological meaning. 
Although it would have been of interest to use CMRglc values in this study, these data were 
not available to us, as they require invasive arterial blood sampling. However, our method 
allowed us to highlight both the most and the least altered structures, according to our goal. 
Another methodological issue regarding PET concerns the spatial normalization: some 
authors have suggested that voxel-based methods entail problems with spatial alignment of 
relatively small structures like the hippocampus, which is subject to high anatomic variability. 
Since the age-related hippocampal changes constitute an important issue, in order to ensure 
that our voxel-based SPM findings were not due to a spatial normalization problem, we have 
performed further complementary analyses, based on Mosconi et al. [51] and termed 
HipMask. This method considers only those hippocampal voxels common to a high majority 
of subjects, thus reducing errors due to spatial normalization and anatomical mismatch. Using 
this method, the results were in agreement with the SPM analysis: there was a positive 
correlation between relative metabolic hippocampal ratios and age (r = .51, p < .001). 
Moreover, we found substantial correlations between the measures obtained in each subject 
using the HipMask method, and the intensity values extracted from the voxel-based analysis 
in the left [-36;-14;-18] and right [38;-22;-12] hippocampal peaks (r = .73 and r = .70, 
respectively, p < .001 for both), suggesting that the SPM findings are robust and not due to 
spatial normalization errors. 
Structural MRI  
Using VBM to address regional volumetric changes could be open to criticisms 
notably for structures such as the hippocampus. However, we chose to use this approach (for 
both MR and PET data sets) not only to objectively study the whole brain, but also to show 
local changes. For instance, we found an absolute GM loss in the posterior part of the 
hippocampus, but a lesser GM loss in its anterior part. However, we also performed 
complementary ROI analysis centred on the head of the right hippocampus in the whole 
sample (N = 45), in order to compare the SPM- and ROI-derived results. To this end, we have 
manually drawn each subject‟s head of the hippocampus. The anatomical boundaries used for 
hippocampus head segmentation were as follows: the principal orientation for segmentation 
was the coronal view, neither the amygdala nor the entorhinal cortex were included; ROI 
drawing was performed in the antero-posterior direction, the ROI including the subiculum and 
the uncus up to its head. The ROIs were expressed in mm
3
, and these raw volumes were 
normalized by the global mean, i.e., the mean intensity value of all the voxels, to be as 
consistent as possible regarding the comparison with VBM data which were also normalized 
by these values. The correlation between age and hippocampal head volume was r = .07 (p = 
.65), i.e. there is no hippocampal head volume decrease with normal aging (Figure 2) (see 
[24] for similar results). This result fits well with our interpretation of the voxel-based 
analysis. Of note, it is not surprising not to find a significant positive correlation, since the 
ROIs do not correspond exactly to the cluster generated by SPM, which included the uncus 
except its head, and part of the subiculum, entorhinal cortex and amygdala. Moreover, we 
have noted the wide variability of the anterior hippocampal volume across all age ranges, a 
point also highlighted in a very recent study [41]. The purpose of the authors was to determine 
whether there were differences in the variance of the whole hippocampal volume associated 
with age. They showed that the variance of hippocampal volume was not different in young 
and older adults, and they gave an interesting discussion about the large hippocampal volume 
inter-individual variability they observed in young healthy subjects.    
Limitations of the study 
This study has a few potential limitations. Firstly, due to the disparity between PET and MR 
spatial resolution, both data sets could not be directly compared. However, providing 
quantitative or statistical comparison between the degree of atrophy and hypometabolism was 
not the aim of the present study. Secondly, we note the remote possibility of age effects on 
intrinsic MR signal and contrast. Thirdly, we admit that the accuracy of PVC algorithms is 
highly dependent on the degree of accuracy achieved by the MRI-PET realignment and MRI 
segmentation procedures, as assessed in many previous studies (for reviews, see [61,74,88]). 
Although there is no given segmentation or PVE correction algorithms providing the best 
results under all conditions, the SPM segmentation algorithm seems to be more particularly 
recommended for clinical data [88], and the modified Müller-Gärtner PVE correction 
algorithm seems to be the most accurate voxel-based method, and the least dependent on 
segmentation errors [61]. Under these conditions, and considering the fact that coregistration 
and segmentation have been individually checked for accuracy, we can consider that we have 
done our best to reduce (although not totally exclude) the risk of realignment and 
segmentation errors. Finally, our cross-sectional study is not adequate to conclude definitively 
on the issue of the high or low level of impairment of the hippocampus, notably because such 
studies could be influenced by cohort effects. Although a longitudinal PET-MR combined 
study would obviously be of considerable interest, the advantage of this approach relative to 
cross-sectional designs has been occasionally [40,65], but not consistently [27,75], shown. 
 
Conclusion 
Overall, the neurobiological changes in normal aging highlighted in this study support 
the developmental theory whereby brain changes follow the phylogenetic and ontogenetic 
axes, and are consistent with age-related changes in memory performance. Our findings also 
highlight the differences between brain impairment associated with normal aging and those 
which characterize Alzheimer‟s disease. It is well-known that in prodromal Alzheimer‟s 
disease, the hippocampus is the first to become atrophic [14], while the posterior cingulate 
cortex undergoes early hypometabolism [15,53]. In our study of healthy subjects, we found 
the reverse pattern, i.e. the anterior hippocampal formation volume and the posterior cingulate 
glucose metabolism were the least altered, signaling the parting of the ways between 
normality and pathology. 
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Fig.1. Structural (A) and 
18
FDG uptake (B) changes occurring in normal aging. (A1) Three-
dimensional rendering (top), sagittal view (bottom) and scatterplots of adjusted activity value 
of the absolute GM loss in the frontal cortex (peak coordinates [x; y; z] ↔ [49; 13; 47]; r = -
.64) and body of the hippocampus ([x; y; z] ↔ [17; -30; -13]; r = -.51) as a function of age. 
(A2) Three-dimensional rendering (top), sagittal view (bottom) and the scatterplot of relative 
adjusted activity value in the right anterior hippocampal area as a function of age ([; y; z] ↔ 
[21; -9; -29]; r = .65)*. (B1) Three-dimensional rendering showing highest 
18
FDG uptake 
decrease and the scatterplot of relative adjusted activity value in the frontal cortex as a 
function of age ([x; y; z] ↔ [8; 54; 36]; r = -.66). (B2) Three-dimensional rendering (centre) 
showing regions of lowest 
18
FDG uptake decrease as a function of age, principally in the right 
posterior cingulate cortex (sagittal view, right) ([x; y; z] ↔ [14; -48; 32]; r = .68) and mesial 
temporal regions (coronal view, left) ([x; y; z] ↔ [38; -22; -12]; r = .64)*. Results are 
displayed at p<.01 FDR corrected for multiple comparisons at the voxel level (extent of 
threshold at least 20 contiguous voxels), and superimposed onto the specific prior created 
from the VBM analysis described in section 2.2.  
 *These positive correlations do not reflect a genuine increase in GM volume or 
18
FDG uptake 
with age. Because the absolute values have been divided by the global mean in these analyses, 
the decrease of the global mean induced an increase of the relative values with age, indicating 
that the highlighted regions were those that undergo the least age-related GM loss and 
decreased 
18
FDG uptake.  
 
Fig. 2. Scatterplot of the association between age and hippocampal‟s head volumes (in mm3) 
assessed with ROI methodology. 
 
Tab.1. Principal clusters of absolute GM volume loss as a function of age, with their main 
peaks. The labelling has been adjusted to the specific template created with the VBM 
processing (p<.01 FDR corrected threshold for multiple comparisons). Note: k = cluster size 
(in voxels). BA: Brodmann Area. L: left, R: right. ant = anterior ; inf = inferior; med = 
medial;  mid = middle ; operc = operculum ; post = posterior ; SMA = supplementary motor 
area ; sup = superior. L = left ; R = right. 
 
Tab.2. Principal clusters of lowest GM volume loss as a function of age, with their main 
peaks. (see legend Table 1) 
 
Tab.3. Principal clusters of highest 
18
FDG uptake decrease as a function of age, with their 
main peaks. (see legend Table 1) 
Tab.4. Principal clusters of lowest 
18
FDG uptake decrease as a function of age, with their 













Table 1 Absolute GM volume loss as a function of age 
TABLE 1: Absolute GM volume loss as a function of age 
MNI 
coordinates  
tvalue k labeling BA 
x y z         
49 13 47 5.44 35973 Orbitofrontal mid R 11/47 
     Frontal inf/mid/sup R 6/8/9/10/44/45/46 
     Pre/post-central R 3/4/43 
43 -10 20 4.69 6231 Insula/Heschl/Rolandic operc/ Temporal sup R 48/22 
-26 4 65 5.14 36619 orbitofrontal inf/mid/sup L 11/46/47 
     Frontal inf/mid/sup L 8/9/44/45/46 
     Precentral L 6 
     Insula/Rolandic operc/Heschl L 48 
5 48 49 5.06 2889 Frontal sup med R 9/32 
     SMA R 8 
     Cingulate ant/mid R 32 
-3 46 49 4.07 2722 Frontal sup med L 9 
     SMA L 6/8 
3 46 -29 3.55 144 Rectus R 11 
-2 48 -28 3.34 46 Rectus L 11 
-29 -85 40 6.20 11544 Occipital mid/sup L 18/19 
     Parietal inf/sup L 7 
31 -79 43 5.24 10698 Occipital mid/sup/Cuneus R 19 
     Parietal sup/Angular R 7 
-62 -22 40 4.26 895 Postcentral/Supramarginal L 1/2/3/4 
-7 -35 50 3.93 1481 Cingulate mid L 23 
-1 2 5 5.67 7918 Periventricular areas  
     Caudate (tail) L/R   
     Thalamus (anterior nuclei) R  
-43 -51 16 4.08 216 Temporal mid L 21 
17 -30 -13 3.89 307 
Lingual, parahippocampal, hippocampus 
(post) R 
27/30 
54 -23 -12 3.54 700 Temporal mid/sup R 21/22 
-46 -46 -41 5.13 31567 Cerebellum L  
     Parahippocampal L 27/30 
36 -43 -44 5.02 20725 Cerebellum R  






Table 2 Lowest GM volume loss as a function of age 
TABLE 2: Lowest GM volume loss as a function of age 
MNI coordinates tvalue k labeling BA 
x y z         
21 -9 -29 5.68 1902 Entorhinal R   28/36 
     Hippocampus (ant) R  
     Amygdala R  
-16 -19 5 5.70 626 Thalamus (lateral nuclei) L  
19 -21 5 5.63 768 Thalamus (lateral nuclei) R  
8 -99 4 4.76 46 Calcarine R 17 
0 -27 -12 5.83 828 Brainstem   
   
Table 3 Highest 
18
FDG uptake decrease as a function of age 
 
TABLE 3: Highest 
18
FDG uptake decrease as a function of age 
MNI 
coordinates 
tvalue k labeling BA 
x y z         
-4 20 66 6.46 2681 Frontal mid/sup/sup med L 9/10 
     Precentral/SMA L 6/8 
     Cingulate ant/mid 32 
6 20 66 6.05 1520 Frontal mid/sup/sup med R 8/9/10 
     SMA R 6 
     Cingulate mid/ant R 32 
54 20 34 5.95 463 Precentral R 6 
     Frontal inf/mid R 44/9 
-40 14 -10 5.46 481 Orbitofrontal inf  L 45/47 
     Insula L 48 
-2 14 -22 4.97 84 Rectus L  11 
2 16 -22 4.87 64 Rectus R 11 
46 22 -6 4.73 206 Orbitofrontal inf R 45/47 
     Insula R 48 
-36 -52 56 7.54 1372 Parietal inf/sup/supramarginal L 7/40 
     Occipital mid/sup/Angular L 19/39 
58 -26 50 5.01 740 Supramarginal/parietal inf R 2/3/40 
30 -82 38 4.39 209 Occipital mid/sup R 7/19 
-46 16 -16 4.98 162 Temporal pole sup L 38 
48 12 -14 4.42 99 Temporal pole sup R 38 
58 -66 22 4.05 82 Temporal mid/sup/angular R 22/39 








Table 4 Lowest 
18
FDG uptake decrease as a function of age 
 
TABLE 4: Lowest 
18
FDG uptake decrease as a function of age 
MNI 
coordinates 
tvalue k labeling BA 
x y z         
26 -64 18 7.60 6071 Amygdala R  
     Hippocampus R  
     Parahippocampal R 36 
     Cingulate post R 30 
     Fusiform R 37 
     Calcarine/occipital inf/lingual R 17/18/19 
     Cuneus R 17 
     Precuneus R 7 
     Temporal inf/mid/sup R 21/22 
     Pallidum - Putamen R  
     Insula/Rolandic operc R  48 
-36 -16 22 6.68 3747 Amygdala L  
     Hippocampus L  
     Parahippocampal L 36 
     Fusiform L 37 
     Calcarine/occipital inf/lingual L 17/18/19 
     Temporal inf/mid L 21/22 
     Pallidum - Putamen L  
     Insula/Rolandic operc L  48 
-16 -16 8 5.83 145 Thalamus (lateral nuclei) L  
18 -14 10 5.40 95 Thalamus (lateral nuclei) R  
44 -10 30 5.53 177 Pre/Post-central R 3/4 
-44 -14 30 4.77 217 Postcentral L 3/4 
-30 -46 38 4.91 42 Parietal inf/Angular L 40 
-16 -36 38 4.69 64 Cingulate mid L 23 
16 -20 42 4.18 26 Cingulate mid R 23 
-10 -60 -36 5.34 412 Cerebellum L/R   
 
   
 
